Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Profound Ventures invests in seed-stage companies within healthcare sectors such as diagnostics, digital software, medical devices, and therapeutics. Their strategy emphasizes solutions that promote health and wellness, particularly those addressing chronic pain and emotional suffering. The firm seeks to reverse incentives in the healthcare system that profit from sickness.
Notable portfolio companies include Proove Genomics, specializing in pain management diagnostics; Outcomeus, focused on clinical monitoring in pain and orthopedics; Cogmotos, developing new approaches for postoperative delirium; Labarium, enhancing precision insights in medical testing; HumAInity AI, a pre-launch AI platform for concierge-level care; and BrainCode, a pre-launch liquid biopsy platform for traumatic brain injuries.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.